Literature DB >> 23312087

Progression of ulcerative dermatitis lesions in C57BL/6Crl mice and the development of a scoring system for dermatitis lesions.

Anna L Hampton1, Gerald A Hish, Muhammad N Aslam, Edward D Rothman, Ingrid L Bergin, Kathleen A Patterson, Madhav Naik, Tejaswi Paruchuri, James Varani, Howard G Rush.   

Abstract

Ulcerative dermatitis (UD) is a common, spontaneous condition in mice with a C57BL/6 background. Although initial lesions may be mild, UD is a progressive disease that often results in ulcerations or debilitating fibrotic contractures. In addition, lesions typically are unresponsive to treatment. Euthanasia is often warranted in severe cases, thereby affecting study outcomes through the loss of research subjects. Because the clinical assessment of UD can be subjective, a quantitative scoring method and documentation of the likely time-frame of progression may be helpful in predicting when animals that develop dermatitis should be removed from a study. Such a system may also be helpful in quantitatively assessing success of various treatment strategies and be valuable to clinical laboratory animal veterinarians. In this 1.5-y, prospective cohort study, we followed 200 mice to monitor the development and course of UD. Mice were examined every 2 wk. A clinical sign (alopecia, pruritus, or peripheral lymphadenopathy) was not identified that predicted development of UD lesions in the subsequent 2-wk period. Once UD developed, pruritus, the character of the lesion (single or multiple crust, coalescing crust, erosion, or ulceration), and the size of the lesion were the only parameters that changed (increased) over the course of the disease. Pruritus was a factor in the rapid progression of UD lesions. We used these findings to develop a quantitative scoring system for the severity of UD. This enhanced understanding of the progression of UD and the quantitative scoring system will enhance the monitoring of UD.

Entities:  

Mesh:

Year:  2012        PMID: 23312087      PMCID: PMC3447447     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  33 in total

1.  Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans.

Authors:  J P Sundberg; D Taylor; G Lorch; J Miller; K A Silva; B A Sundberg; D Roopenian; L Sperling; D Ong; L E King; H Everts
Journal:  Vet Pathol       Date:  2010-09-22       Impact factor: 2.221

2.  Association between hair-induced oronasal inflammation and ulcerative dermatitis in C57BL/6 mice.

Authors:  Sandra M Duarte-Vogel; Gregory W Lawson
Journal:  Comp Med       Date:  2011-02       Impact factor: 0.982

3.  IL-6, VEGF, KC and RANTES are a major cause of a high irritant dermatitis to phthalic anhydride in C57BL/6 inbred mice.

Authors:  Chang-Joon Bae; Sun-Bo Shim; Seung-Wan Jee; Su-Hae Lee; Mi-Ran Kim; Jae-Won Lee; Chang-Kyu Lee; Dae-Youn Hwang
Journal:  Allergol Int       Date:  2010-09-25       Impact factor: 5.836

4.  A mineral-rich extract from the red marine algae Lithothamnion calcareum preserves bone structure and function in female mice on a Western-style diet.

Authors:  Muhammad Nadeem Aslam; Jaclynn M Kreider; Tejaswi Paruchuri; Narasimharao Bhagavathula; Marissa DaSilva; Ronald F Zernicke; Steven A Goldstein; James Varani
Journal:  Calcif Tissue Int       Date:  2010-02-24       Impact factor: 4.333

5.  CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling.

Authors:  S Hida; K Ogasawara; K Sato; M Abe; H Takayanagi; T Yokochi; T Sato; S Hirose; T Shirai; S Taki; T Taniguchi
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

6.  A mineral-rich red algae extract inhibits polyp formation and inflammation in the gastrointestinal tract of mice on a high-fat diet.

Authors:  Muhammad N Aslam; Tejaswi Paruchuri; Narasimharao Bhagavathula; James Varani
Journal:  Integr Cancer Ther       Date:  2010-02-11       Impact factor: 3.279

7.  Maropitant citrate for treatment of ulcerative dermatitis in mice with a C57BL/6 background.

Authors:  Misty J Williams-Fritze; Jodi A Carlson Scholz; Caroline Zeiss; Yanhong Deng; Steven R Wilson; Rebekah Franklin; Peter C Smith
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-03       Impact factor: 1.232

8.  Endpoints for mouse abdominal tumor models: refinement of current criteria.

Authors:  Eden V Paster; Kimberly A Villines; Debra L Hickman
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

9.  Oral administration of paramylon, a beta-1,3-D-glucan isolated from Euglena gracilis Z inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice.

Authors:  Akihiko Sugiyama; Sayaka Hata; Kengo Suzuki; Eriko Yoshida; Ryohei Nakano; Sharbanee Mitra; Ryo Arashida; Yuta Asayama; Yukinori Yabuta; Takashi Takeuchi
Journal:  J Vet Med Sci       Date:  2010-02-16       Impact factor: 1.267

10.  A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia.

Authors:  Stephan J Guyenet; Stephanie A Furrer; Vincent M Damian; Travis D Baughan; Albert R La Spada; Gwenn A Garden
Journal:  J Vis Exp       Date:  2010-05-21       Impact factor: 1.355

View more
  21 in total

1.  Comparison of 3 Topical Treatments against Ulcerative Dermatitis in Mice with a C57BL/6 Background.

Authors:  Carmen R Michaud; Jing Qin; William R Elkins; Alfonso S Gozalo
Journal:  Comp Med       Date:  2016-04       Impact factor: 0.982

2.  Incidence rates of spontaneous disease in laboratory mice used at a large biomedical research institution.

Authors:  James O Marx; Angela K Brice; Raymond C Boston; Abigail L Smith
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-11       Impact factor: 1.232

3.  Ulcerative Dermatitis in C57BL/6NCrl Mice on a Low-Fat or High-Fat Diet With or Without a Mineralized Red-Algae Supplement.

Authors:  Anna L Hampton; Muhammad N Aslam; Madhav K Naik; Ingrid L Bergin; Ron M Allen; Ronald A Craig; Steve L Kunkel; Indiradevi Veerapaneni; Tejaswi Paruchuri; Kathleen A Patterson; Edward D Rothman; Gerald A Hish; James Varani; Howard G Rush
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-09       Impact factor: 1.232

4.  HTR7 Mediates Serotonergic Acute and Chronic Itch.

Authors:  Takeshi Morita; Shannan P McClain; Lyn M Batia; Maurizio Pellegrino; Sarah R Wilson; Michael A Kienzler; Kyle Lyman; Anne Sofie Braun Olsen; Justin F Wong; Cheryl L Stucky; Rachel B Brem; Diana M Bautista
Journal:  Neuron       Date:  2015-06-11       Impact factor: 17.173

5.  Long-term Western diet intake leads to dysregulated bile acid signaling and dermatitis with Th2 and Th17 pathway features in mice.

Authors:  Prasant Kumar Jena; Lili Sheng; Kyle Mcneil; Thinh Q Chau; Sebastian Yu; Maija Kiuru; Maxwell A Fung; Samuel T Hwang; Yu-Jui Yvonne Wan
Journal:  J Dermatol Sci       Date:  2019-06-08       Impact factor: 4.563

6.  Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia.

Authors:  Sally Kelliny; Jing Xiong; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Neurotox Res       Date:  2021-10-02       Impact factor: 3.911

7.  Scratching Responses to Epidermal Injury in C57BL/6, DBA/2, BALB/c, and CD1 Mice.

Authors:  Jennifer L Sargent; Christiane V Löhr; Helen E Diggs
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

8.  Retrospective Evaluation of Nail Trimming as a Conservative Treatment for Ulcerative Dermatitis in Laboratory Mice.

Authors:  Cynthia G Alvarado; Craig L Franklin; Lonny W Dixon
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

Review 9.  Systematic Literature Review of Risk Factors and Treatments for Ulcerative Dermatitis in C57BL/6 Mice.

Authors:  Jennifer L Sargent; Nathan J Koewler; Helen E Diggs
Journal:  Comp Med       Date:  2015-12       Impact factor: 0.982

10.  Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice.

Authors:  Alexander A Pieper; Alexander L Rakhmilevich; Daniel V Spiegelman; Ravi B Patel; Jen Birstler; Won Jong Jin; Peter M Carlson; Deborah H Charych; Jacquelyn A Hank; Amy K Erbe; Willem W Overwijk; Zachary S Morris; Paul M Sondel
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 12.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.